⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL524425 | 0.97 | — | — | |
| Bromide SCHEMBL2470982 | 0.97 | — | — | |
| Bromide SCHEMBL29096722 | 0.94 | — | — | |
| Bromide SCHEMBL1649333 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL4408205 | 0.87 | CYP1A2 (0.76) | — | |
| SCHEMBL9197363 | 0.82 | — | — | |
| Bromide SCHEMBL4434174 | 0.80 | CYP1A2 (0.95) | — | |
| Bromide SCHEMBL17747992 | 0.80 | HRH4 (1.00) | — | |
| SCHEMBL29096739 | 0.75 | — | — | |
| SCHEMBL9193111 | 0.75 | CYP1A2 (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 548 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744663-A2 | SKIN COMPOSITION | Eaderm Co., Ltd. (JP) | 2026-05-20 | — | — | EP | claimed |
| WO-2026090542-A1 | BETA-AMINO-ESTER AND BETA-THIOL-ESTER CONTAINING POLYMERS FOR DRUG DELIVERY AND PHARMACEUTICAL USES | EMORY UNIVERSITY (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4659023-A1 | METHOD OF PREDICTING SUCCESS OF A CANCER THERAPY | Immusmol SAS (FR) | 2025-12-10 | — | — | EP | claimed |
| WO-2024224296-A2 | TARGETED PHARMACEUTICAL COMPOSITIONS TO TREAT NEUROLOGICAL CONDITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-10-31 | — | — | WO | claimed |
| WO-2024161038-A1 | METHOD OF PREDICTING SUCCESS OF A CANCER THERAPY | IMMUSMOL SAS (FR) | 2024-08-08 | — | — | WO | claimed |
| CN-118079006-A | Skin composition | 国立大学法人东京医科齿科大学 | 2024-05-28 | — | — | CN | claimed |
| EP-4277592-A1 | TOPICAL COMPOSITION | Liliger Ltd (IL) | 2023-11-22 | — | — | EP | claimed |
| EP-3473710-B1 | SACCHARIFICATION REACTION SOLUTION, SACCHARIFYING ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | NISSAN CHEMICAL CORP (JP) | 2023-09-27 | — | — | EP | claimed |
| CN-116685302-A | Topical compositions | 利勒格有限公司 | 2023-09-01 | — | — | CN | claimed |
| US-20220331389-A1 | SKIN COMPOSITION | EADERM CO., LTD. (JP) | 2022-10-20 | — | — | US | claimed |
| US-6811965-B2 | REPERFUSION SOLUTION FOR USE IN THE PRESERVATION OF ORGAN TISSUE | HERMACELL PERFUSION, INC. | 2004-11-02 | — | — | US | claimed |
| US-20040072809-A1 | Antiinflammatory agents; analgesics; dilation; reducing pressure; therapy for vision defects | OMEROS CORPORATION | 2004-04-15 | — | — | US | claimed |
| WO-2004010894-A2 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | OMEROS CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-20030104348-A1 | Kidney perfusion solution containing nitric oxide donor | HERMACELL PERFUSION, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2001065935-A1 | KIDNEY PERFUSION SOLUTION CONTAINING NITRIC OXIDE DONOR | VODOVOTZ YORAM (US) | 2001-09-13 | — | — | WO | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0426100-B1 | Stabilized enzyme compositions | ABBOTT LAB (US) | 1994-12-14 | — | — | EP | claimed |
| CN-1095710-A | Enzyme Inhibitors | WELLCOME FOUND (GB) | 1994-11-30 | — | — | CN | claimed |
| EP-0245669-B1 | Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs | FLOERSHEIM GEORG L (CH) | 1993-12-01 | — | — | EP | claimed |